Clinical trial
Galectin-3, Fecal Calprotectin and Intestinal Ultrasound for Assessing the Effects of a Modified Mediterranean Diet on Ulcerative Colitis Disease Activity
NCT07857447 is registered in ClinicalTrials.gov with University Hospital Sestre Milosrdnice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Galectin-3, Fecal Calprotectin and Intestinal Ultrasound for Assessing the Effects of a Modified Mediterranean Diet on Ulcerative Colitis Disease Activity
- Lead sponsor
- University Hospital Sestre Milosrdnice
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 62 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis (uc)